4 |
odac cancer
|
29 900 |
-1
|
2014-08-30
|
4 |
pam50
|
30 800 |
-3
|
2014-09-04
|
4 |
jmen study
|
38 600 |
2
|
2015-08-25
|
4 |
geron halted
|
95 700 |
0
|
2014-09-04
|
4 |
slamon
|
149 000 |
0
|
2015-08-26
|
4 |
active spy trial
|
636 000 |
-3
|
2014-12-31
|
4 |
cancer education games
|
87 400 000 |
45
|
2014-08-05
|
5 |
receptor tvdr
|
23 100 |
0
|
2014-10-16
|
5 |
ags cancer treatment
|
78 300 |
0
|
2014-03-10
|
5 |
top 10 oncologists in u.s.
|
2 350 000 |
0
|
2014-07-03
|
5 |
survival phase
|
150 000 000 |
5
|
2015-08-19
|
6 |
gtx pancreatic cancer
|
10 900 |
0
|
2014-04-24
|
6 |
cml gene test
|
191 000 |
0
|
2016-01-19
|
6 |
tasigna recent publications
|
454 000 |
5
|
2013-10-17
|
7 |
treatment guidelines tnbc
|
18 900 |
0
|
2014-01-26
|
7 |
avastin odac
|
96 500 |
0
|
2014-07-05
|
7 |
skin toxicity
|
27 100 000 |
0
|
2014-01-13
|
7 |
combined kit
|
33 400 000 |
0
|
2014-08-26
|
8 |
abiraterone clinical trials
|
53 400 |
0
|
2013-11-19
|
8 |
t-dm1
|
779 000 |
-6
|
2014-08-17
|
8 |
medicaid reimbursement rates for capecitabine
|
853 000 |
18
|
2014-01-29
|
8 |
educational cancer games
|
8 740 000 |
0
|
2014-05-30
|
8 |
r-chop chemo to begin tuesday
|
14 500 000 |
11
|
2015-06-19
|
8 |
peer exchange
|
20 300 000 |
13
|
2013-10-27
|
9 |
eribulin
|
57 000 |
13
|
2013-10-22
|
9 |
fulvestrant breast ca oncologist
|
285 000 |
1
|
2012-03-17
|
9 |
skeletal related events
|
6 220 000 |
-1
|
2013-11-08
|
9 |
oncology reports offer
|
39 800 000 |
0
|
2013-11-02
|
9 |
mike brains financial facts
|
94 900 000 |
26
|
2014-07-17
|
10 |
sirtcan
|
1 880 |
1
|
2015-08-24
|
10 |
i spy esserman
|
5 260 |
-6
|
2014-10-22
|
10 |
aua prostate cancer screening guidelines
|
23 400 |
-3
|
2015-11-19
|